How can we further improve radiotherapy for stage-III non-small-cell lung cancer?

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Beckmann, Gabriele K ^a,b   Kölbl, Oliver ^a   Krieger, Thomas ^a   Wulf, Jörn ^a   Flentje, Michael P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

CT PET fusion; Dose escalation; Dose volume dependency of tumour control; Elective nodal irradiation; IMRT; Locally advanced non small cell lung cancer; Target motion

Indexed keywords

CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER STAGING; CONFERENCE PAPER; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 8444250338     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.982     Document Type: Conference Paper

References (75)

1. McLoud T.C., Bourgouin P.M., Greenberg R.W., Kosiuk J.P., TempLeton P.A., Shepard J.A., Moore E.H., Wain J.C., Mathisen D.J., and Grillo H.C. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling Radiology 182 2 1992 319 323
2. Dwamena B.A., Sonnad S.S., Angobaldo J.O., and Wahl R.L. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s -- meta-analytic comparison of PET and CT Radiology 213 1999 530 536
3. Mac Manus M.P., and Hicks R.J. PET scanning in lung cancer: current status and future directions Semin Surg Oncol 21 3 2003 149 155
4. Schmidt S., Nestle U., Walter K., Licht N., Ukena D., Schnabel K., and Kirsch C.M. Optimierung der Bestrahlungsplanung beim nicht-kleinzelligen Bronchialkarzinom (NSCLC) mit Hilfe von 18 FDG-PET Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET Nuklearmedizin 41 5 2002 217 220
5. Hoekstra C.J., Stroobants S.G., Hoekstra O.S., Vansteenkiste J., Biesma B., Schramel F.J., van Zandwijk N., van Tinteren H., and Smit E.F. The value of [18F]fLuoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment Lung Cancer 39 2 2003 151 157
6. Verboom P., van Tinteren H., Hoekstra O.S., Smit E.F., van den Bergh J.H., Schreurs A.J., Stallaert R.A., van Velthoven P.C., Comans E.F., Diepenhorst F.W., van Mourik J.C., Postmus P.E., Boers M., Grijseels E.W., TeuLe G.J., Uyl-de Groot C.A. PLUS study group Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study Eur J Nucl Med Mol Imaging 30 11 2003 1444 1449
7. Mac Manus M.P., Wong K., Hicks R.J., Matthews J.P., Wirth A., and Ball D.L. Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center Int J Radiat Oncol Biol Phys 52 2 2002 351 361
8. Choi N.C., Fischman A.J., Niemierko A., Ryu J.S., Lynch T., Wain J., Wright C., Fidias P., and Mathisen D. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 54 4 2002 1024 1035
9. Ryu J.S., Choi N.C., Fischman A.J., Lynch T.J., and Mathisen D.J. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathoLogy Lung Cancer 35 2 2002 179 187
10. Liengswangwong V., and Bonner J.A. Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer Semin Radiat Oncol 10 2000 308 314
11. Sibley G.S. Radiotherapy for patients with medically inoperable stage I non small cell lung carcinoma. Smaller doses and higher doses. A review Cancer 82 1998 433 438
12. Chien C.R., Chen S.W., Hsieh C.Y., Liang J.A., Yang S.N., Huang C.Y., and Lin F.J. Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: a preliminary report Jpn J Clin Oncol 31 2 2001 55 60
13. Williams T.E., Thomas C.R. Jr, and Turrisi A.T. 3rd Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation Semin Radiat Oncol 10 4 2000 315 323
14. Emami B., Mirkovic N., Scott C., Byhardt R., Graham M.V., James Andras E., John M., Herskovic A., Urtasun R., Asbell S.O., Perez C.A., and Cox J. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data Lung Cancer 41 2 2003 207 214
15. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., and Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 50 3 2001 681 685
16. Senan S., Burgers S., Samson M.J., van Klaveren R.J., Oei S.S., van Sörnsen de Koste J., Voet P.W., Lagerwaard F.J., van Haarst J.M., Aerts J.G.J.V., and van Meerbeeck J.P. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol Phys 54 4 2002 999 1006
17. Elias A.D., Skarin A.T., Leong T., Mentzer S., Strauss G., Lynch T., Shulman L., Jacobs C., Abner A., Baldini E.H., Frei E. 3rd, and Sugarbaker D.J. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC) Lung Cancer 17 1 1997 147 161
18. Betticher D.C., Hsu Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., Schmid R.A., Pless M., Habicht J., Roth A.D., Spiliopoulos A., Stahel R., Weder W., Stupp R., Egli F., Furrer M., Honegger H., Wernli M., Cerny T., and Ris H.B. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 9 2003 1752 1759
19. Shimizu S., Shirato H., Ogura S., Akita-Dosaka H., Kitamura K., Nishioka T., Kagei K., Nishimura M., and Miyasaka K. Detection of lung tumor movement in real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 51 2 2001 304 310
20. Lax I., Blomgren H., and Larson D. Näslund D extracranial stereotactic radiosurgery of localized targets J Radiosurg 1 2 1998 135 148
21. Wulf J., Haedinger U., Oppitz U., Olshausen B., and Flentje M. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame Radiother Oncol 57 2000 225 236
22. Wulf J., Haedinger U., Oppitz U., Thiele W., and Flentje M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver Radiother Oncol 66 2003 141 150
23. Ross C.S., Hussey D.H., Pennington E.C., Stanford W., and Doornbos J.F. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography Int J Radiat Oncol Biol Phys 18 3 1990 671 677
24. Lagerwaard F.J., Van Sornsen de Koste J.R., Nijssen-Visser M.R., Schuchhard-Schipper R.H., Oei S.S., Munne A., and Senan S. Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning Int J Radiat Oncol Biol Phys 51 4 2001 932 937
25. Yamada K., Soejima T., Yoden E., Maruta T., Okayama T., and Sugimura K. Improvement of three-dimensional treatment planning models of small lung targets using high-speed multi slice computed tomographic imaging Int J Radiat Oncol Biol Phys 54 4 2002 1210 1216
26. Hof H., Herfarth K.K., and Münter M. Stereotactic single-dose radiotherapy of stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 56 2 2003 335 341
27. Laagerward F.J., Senan S., van Meerbeeck J.P., and Graveland W.J. Has 3D-conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? Radiother Oncol 63 2002 151 157
28. Le Chevalier T., Arriagada R., Quoix E., Ruffie P., Martin M., Tarayre M., Lacombe-Terrier M.J., Douillard J.Y., and Laplanche A. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients J Natl Cancer Inst 836 1991 417 423
29. Cox J.D., Azarnia N., Byhardt R.W., Shin K.H., Emami B., and Pajak T.F. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11 J Clin Oncol 8 9 1990 1543 1555
30. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., and Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee Radiother Oncol 52 2 1999 137 148
31. Bradley J.D., Ieumwananonthachai N., Purdy J.A., Wasserman T.H., Lockett M.A., Graham M.V., and Perez C.A. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 52 1 2002 49 57
32. Etiz D., Marks L.B., Zhou S.M., Bentel G.C., Clough R., Hernando M.L., and Lind P.A. Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 53 4 2002 835 846
33. Winner J., Baier K., Caragiani E., Tschammler A., and Flentje M. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer Int J Radiat Oncol Biol Phys 52 2 2002 382 389
34. Martel M.K., Ten Haken R.K., and Hazuka M.B. Estimation of tumor control probability from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37
35. Belderbos J.S.A., De Jaeger K., and Heemsbergen W.D. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy Radiother Oncol 66 2003 119 126
36. Rosenzweig K.E., Yorke E., Jackson A., Nayak R., Rusch V.W., Kris M.G., Fuks Z., Ling C.C., and Leibel S.A. Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 57 Suppl 2 2003 S417 S418
37. Maguire P.D., Marks L.B., Sibley G.S., Herndon J.E. 2nd, Clough R.W., Light K.L., Hernando M.L., Antoine P.A., and Anscher M.S. 73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer J Clin Oncol 19 3 2001 705 711
38. Bradley J.D., Graham M.V., Winter K.W., Purdy J.A., Komaki R., Roa W.H., Ryu J.K., Bosch W., and Emami B. Acute and late toxicity results of RTOG 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 57 Suppl 2 2003 S137 S138
39. Hayman J.A., Martel M.K., Ten Haken R.K., Normolle D.P., Todd R.F. 3rd, Littles J.F., Sullivan M.A., Possert P.W., Turrisi A.T., and Lichter A.S. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial J Clin Oncol 19 1 2001 127 136
40. Engelsman M., Remeijer P., van Herk M., and Lebesque J.V. Field size reduction enables iso-NTCP escalation of tumor control probability for irradiation of lung tumors Int J Radiat Oncol Biol Phys 51 5 2001 1290 1298
41. Nakagawa K., Aoki Y., Tago M., Terahara A., and Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms Int J Radiat Oncol Biol Phys 48 2 2000 449 457
42. Hara R., Itami J., Kondo T., and Aruga T. Stereotactic single high dose irradiation of lung tumors under respiratory gating Radiother Oncol 63 2002 159 163
43. Whyte R.I., Crownover R., Murphy M.J., and Martin D.P. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial Ann Thorac Surg 75 2003 1097 1101
44. Blomgren H., Lax I., Naslund I., and Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients Acta Oncol 34 6 1995 861 870
45. Nagata Y., Negoro Y., and Aoki T. Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame Int J Radiat Oncol Biol Phys 52 4 2002 1041 1046
46. Timmerman R.D., Papiez L., and Mc Garry R. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
47. Lee S., Choi E.K., and Park H.J. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung Lung Cancer 40 2003 309 315
48. Uematsu M., Shioda M., and Suda A. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience Int J Radiat Oncol Biol Phys 51 3 2001 666 670
49. Onimaru R., Shirato H, Shimizu S., and Kitamura K. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135
50. Wulf J., Hädinger U., Oppitz U., Thiele W., and Flentje M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver Radiother Oncol 66 2 2003 141 150
51. Derycke S., De Gersem W.R., Van Duyse B.B., and De Neve W.C. Conformal radiotherapy of Stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams Int J Radiat Oncol Biol Phys 41 4 1998 771 777
52. Zelefsky M.J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C.C., Amols H., Venkatraman E.S., and Leibel S.A. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 5 2002 1111 1116
53. Pirzkall A., Debus J., Haering P., Rhein B., Grosser K.H., Hoss A., and Wannenmacher M. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience Int J Radiat Oncol Biol Phys 55 2 2003 362 372
54. Mannitz S., Stuschke M., Bohsung J., Moys A., Reng I., Wurm R., and Budach V. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer -- a planning study Strahlenther Onkol 178 11 2002 651 658
55. Underwood L.J., Murray B.R., Robinson D.M., Field G.C., and Roa W.H. An evaluation of forward and inverse radiotherapy planning using Helax-TMS (version 6.0) for lung cancer patients treated with RTOG 93-11 dose-escalation protocol Med Dosim 28 3 2003 167 170
56. Grills I.S., Yan D., Martinez A.A., Vicini F.A., Wong J.W., and Kestin L.L. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation Int J Radiat Oncol Biol Phys 57 3 2003 875 890
57. Fippel M. Fast Monte Carlo dose calculations for photon beams based on the vmc electron algorithm Med Phys 26 1999 1466 1475
58. Ma C.M., Li J.S., Pawlicki T., Jiang S.B., and Deng J. MCDOSE -- a Monte Carlo dose calculation tool for radiation therapy treatment planning Schlegel W. Bortfeld T. Proc 13th Int Conf on the Use of Computer in Radiation Therapy 2000 Springer Heidelberg 123 125
59. Ma C.M., Mok E., Kapur A., Pawlicki T., Findley D., Brain S., Forster K., and Boyer A.L. Clinical implementation of a Monte Carlo treatment planning system Med Phys 26 1999 2133 2143
60. Knöös T., Ahnesjö A., Nilsson P., and Weber L. Limitations of a pencil beam approach to photon dose calculations in lung tissue Phys Med Biol 40 1995 1411 1420
61. Ahnesjö A. Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media Med Phys 16 1989 577 592
62. Klein E.E., Chin L.M., Rice R.K., and Mijnheer B.J. The influence of air cavities on interface doses for photon beams Int J Radiat Oncol Biol Phys 27 1993 419 427
63. Martens C., Reynaert N., De Wagter C., Nilsson P., Coghe M., Palmans H., Thierens H., and De Neve W. Under-dosage of the upper-airway mucosa for small fields in intensity-modulated radiation therapy: A comparison between radiochromic film measurements, Monte Carlo simulations, and collapsed cone convolution calculations Med Phys 29 2002 1528 1535
64. Blomquist M., Li J., Ma C.M., Zackrisson B., and Karlsson M. Comparison between a conventional treatment energy and 50MV photon for the treatment of lung tumours Phys Med Biol 47 2001 889 897
65. Saitoh H., Fujisaki T., Sakai R., and Kunieda E. Dose distribution of narrow beam irradiation for small lung tumor Int J Radiat Oncol Biol Phys 53 2002 1380 1387
66. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation Int J Radiat Oncol Biol Phys 16 6 1989 1623 1630
67. Niemierko A., and Goitein M. Modeling of normal tissue response to radiation: the critical volume model Int J Radiat Oncol Biol Phys 25 1 1993 135 145
68. Oetzel D., Schraube P., Hensley F., Sroka-Perez G., Menke M., and Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis Int J Radiat Oncol Biol Phys 33 2 1995 455 460
69. Kwa S.L., Lebesque J.V., Theuws J.C., Marks L.B., Munley M.T., Bentel G., Oetzel D., Spahn U., Graham M.V., Drzymala R.E., Purdy J.A., Lichter A.S., Martel M.K., and Ten Haken R.K. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients Int J Radiat Oncol Biol Phys 42 1 1998 1 9
70. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., and Perez C.A. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 2 1999 323 329
71. Seppenwoolde Y., Lebesque J.V., de Jaeger K., Belderbos J.S., Boersma L.J., Schilstra C., Henning G.T., Hayman J.A., Martel M.K., and Ten Haken R.K. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability Int J Radiat Oncol Biol Phys 55 3 2003 724 735
72. Jenkins P., D'Amico K., Benstead K., and Elyan S. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART) Int J Radiat Oncol Biol Phys 56 2 2003 360 366
73. Winner J., Jost A., Baier K., and Flentje M. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy Strahlenther Onkol 179 8 2003 548 556
74. Graham M.V., Purdy J.A., Emami B., Matthews J.W., and Harms W.B. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer Int J Radiat Oncol Biol Phys 33 5 1995 993 1000
75. De Jaeger K., Seppenwoolde Y., Boersma L.J., Muller S.H., Baas P., Belderbos J.S., and Lebesque J.V. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer Int J Radiat Oncol Biol Phys 55 5 2003 1331 1340